Trade IART stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Integra LifeSciences Holdings Corporation (IART) is trading at US$13.32, up 0.23% today as of Oct 6, 16:00 EDT. The company has a market capitalisation of US$1.3B. Over the past 52 weeks, IART has traded between US$8.70 and US$20.49. On Syfe you can trade IART with $0 commission and add it to your watchlist.
| Previous close | US$13.29 |
|---|---|
| Market cap | US$1.3B |
| P/E ratio | 5.22 |
| 52-week range | US$8.70 – US$20.49 |
| Volume | 1.34M |
| Exchange | US |
Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Year: 1995
Integra LifeSciences Holdings Corporation (IART) stock is trading at US$13.32, +0.23% from the previous close of US$13.29.
The market cap for Integra LifeSciences Holdings Corporation (IART) stock is approximately US$1.3B.
The price-to-earnings ratio for Integra LifeSciences Holdings Corporation (IART) is 5.22, based on the latest reported earnings.
The 52-week high for Integra LifeSciences Holdings Corporation (IART) stock is US$20.49.
The 52-week low for Integra LifeSciences Holdings Corporation (IART) stock is US$8.70.
Integra LifeSciences Holdings Corporation (IART) does not currently pay a dividend.
Stay on top of IART
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
